Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center. Leukemia 2014 Jun;28(6):1365-8

Date

01/24/2014

Pubmed ID

24451411

Pubmed Central ID

PMC4047185

DOI

10.1038/leu.2014.42

Scopus ID

2-s2.0-84902073992 (requires institutional sign-in at Scopus site)   18 Citations

Author List

Stephens DM, Ruppert AS, Jones JA, Woyach J, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Johnson AJ, Muthusamy N, Heerema NA, Byrd JC

Author

Samantha M. Jaglowski MD, MPH Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Chromosome Deletion
Chromosomes, Human, Pair 17
Female
Follow-Up Studies
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Recurrence, Local
Prognosis
Survival Rate